Email: 
43 Frunzenskaya st., Borovlyany village
Price-list
|
Treatment Name |
Cost of Treatment, USD |
|---|---|
|
ALL, standard risk group |
20000,00 |
|
ALL, intermediate risk group |
30000,00 |
|
ALL, high-risk group |
45000,00 |
|
ALL relapse |
60000,00 |
|
AML |
60000,00 |
|
Hodgkin’s lymphoma |
30000,00 |
|
Non-Hodgkin’s lymphomas |
from 45000.0 |
|
Aplastic anemia (immunosuppressive therapy course) |
50000,00 |
|
Hematopoietic stem cell transplantation (HSCT), autologous |
20000,00 |
|
Hematopoietic stem cell transplantation (HSCT), matched related donor |
70000,00 |
|
Hematopoietic stem cell transplantation (HSCT), haploidentical related donor |
70000,00 |
|
Hematopoietic stem cell transplantation (HSCT), unrelated donor (including order and delivery of graft from Europe/RF/RK) |
90000,00 |
|
Neuroblastoma |
30000,00 |
|
Neuroblastoma with Carziba treatment |
from 250000,00 |
|
DNA vaccination (9 injections) |
6000,00 |
|
Nephroblastoma (with surgical intervention) |
20000,00 |
|
CAR-T therapy (including CAR-T cell cost) for patients under 40 kg |
from 48000,00 |
|
CAR-T therapy (including CAR-T cell cost) for patients over 40 kg |
from 52000,00 |
|
EK cell immunotherapy (2 injections) |
5000,00 |
|
MSC cell therapy for cerebral palsy (with neurologist’s report) |
5000,00 |
|
MSC cell therapy for joint diseases (knee, shoulder) (with orthopedic surgeon’s report) |
2400,00 |
|
Osteosarcoma (without endoprosthesis) |
from 25000.0 |
|
Ewing’s sarcoma (without endoprosthesis) |
40000,00 |
|
Rhabdomyosarcoma |
from 20000 |
|
Retinoblastoma |
from 20000 |
|
Medulloblastoma |
65000,00 |
|
Anaplastic astrocytoma, diffuse intrinsic pontine glioma (DIPG) |
from 20000 |
|
Ependymoma |
from 10000.00 |
|
Cost of endoprosthesis |
from 30000.0 |
